The contractor shall support the characterization of the drug substances in the MPT VR drug product including: (1) particle characteristics (i.e., size, morphology, dispersion throughout the ring…
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $455,080
Award facts
- Opportunity
-
- 75N93022F00002 Solicitation number
- Contract value 100% obligated
- $455,080.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $455,080 |
About this award
The prime contractor, Advanced Bioscience Laboratories, Inc., has been awarded a $455,080 cost plus fixed fee Delivery Order contract by the National Institutes of Health National Institute of Allergy and Infectious Diseases to support the characterization of drug substances in the MPT VR drug product. This includes analyzing the particle characteristics, such as size, morphology, and dispersion throughout the ring layers, of the drug substance following compounding under the Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The period of performance is from September 1, 2022 through August 31, 2024 in Potomac, Maryland.
Description
The contractor shall support the characterization of the drug substances in the MPT VR drug product including: (1) particle characteristics (i.e., size, morphology, dispersion throughout the ring layers, etc.) of the drug substance following compound
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $455,080 on 75N93022F00002.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award